Biosimilar Newsletter Archive

1. 08.16.18 -- What To Watch In The Biosimilar Regulatory Space
   8/16/2018

   08/16/18 Biosimilar Development Newsletter

2. 08.09.18 -- EU Turns Focus To Biosimilar Sustainability Questions
   8/9/2018

   08/09/18 Biosimilar Development Newsletter

3. 08.07.18 -- Speed To Market Strategies For Biosimilar Manufacturers
   8/7/2018
   08/07/18 Biosimilar Development Newsletter
4. 08.02.18 -- Samsung Bioepis: From Biosimilars To Novel Biologics
   8/2/2018

   08/02/18 Biosimilar Development Newsletter

5. 07.26.18 -- 3 Biosimilar Market Access Experiences
   7/26/2018

   07/26/18 Biosimilar Development Newsletter

6. 07.19.18 -- 4 Conversations Integral To Biosimilar Partnerships
   7/19/2018

   07/19/18 Biosimilar Development Newsletter

7. 07.12.18 -- Lit Review Pushback Highlights Areas For Future Study
   7/12/2018

   07/12/18 Biosimilar Development Newsletter

8. 07.05.18 -- FDA's Latest Move Worthy Of Celebration
   7/5/2018

   07/05/18 Biosimilar Development Newsletter

9. 06.29.18 -- Downstream Virus Purification Platforms
   6/29/2018
   06/29/18 Biosimilar Development Newsletter
10. 06.27.18 -- Cell Therapy Solutions For Every Step
    6/27/2018
    06/27/18 Biosimilar Development Newsletter